Literature DB >> 27001198

Body composition analysis using abdominal scans from routine clinical care in patients with Crohn's Disease.

Darcy Quinn Holt1,2, Boyd Josef Gimnicher Strauss2, Kenneth K Lau2,3, Gregory Thomas Moore1,2.   

Abstract

OBJECTIVE: Crohn's Disease is associated with body composition changes, which have important treatment and prognostic implications. Measurement of body composition usually requires dedicated scanning or measurement, with retrospective analysis of existing datasets impossible. We sought to determine whether single slice analysis of abdominal scans, obtained during routine clinical care, in patients with Crohn's Disease accurately predicts body composition compartments.
MATERIALS AND METHODS: Abdominal CT images of patients with Crohn's disease were analyzed and comparison was made with total body fat-free mass, total body fat mass, femoral neck t-score, and other parameters reported from DXA, the reference method.
RESULTS: Thirty-seven subjects were identified, 15 male and 22 female, with a mean age of 43.8 years. There was significant correlation (Pearson r = 0.923, p < 0.001) between skeletal muscle area from CT and total fat-free mass measured by DXA. Similarly, total body fat mass correlated strongly (r = 0.928, p < 0.0001) with subcutaneous fat area. In this cohort of ambulatory Crohn's Disease patients, low muscle mass/sarcopenia was prevalent and predictive of lower bone mineral density.
CONCLUSIONS: Fat mass, fat-free mass, and appendicular skeletal muscle index can be predicted by analysis of a single CT slice in patients with Crohn's Disease. Similar to published data from healthy subjects, the L3 vertebral body level provided the most robust correlation with most parameters. This study represents the first published use of routinely obtained abdominal imaging to demonstrate this relationship - and to predict body composition components - in patients with inflammatory bowel disease.

Entities:  

Keywords:  Body composition; Crohn disease; bone density; sarcopenia; tomography

Mesh:

Year:  2016        PMID: 27001198     DOI: 10.3109/00365521.2016.1161069

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients.

Authors:  Jason D Doles; Kelly A Hogan; Jennifer O'Connor; Andrea E Wahner Hendrickson; Olivia Huston; Aminah Jatoi
Journal:  J Palliat Med       Date:  2018-05-24       Impact factor: 2.947

2.  Low muscle mass at initiation of anti-TNF therapy for inflammatory bowel disease is associated with early treatment failure: a retrospective analysis.

Authors:  D Q Holt; P Varma; B J G Strauss; A S Rajadurai; G T Moore
Journal:  Eur J Clin Nutr       Date:  2017-02-22       Impact factor: 4.016

3.  Preoperative computed tomography-assessed skeletal muscle index is a novel prognostic factor in patients with hepatocellular carcinoma following hepatectomy: a meta-analysis.

Authors:  Liqian Xu; Yuxia Jing; Chen Zhao; Qin Zhang; Xiaohong Zhao; Ji Yang; Lizhen Wu; Yunmei Yang
Journal:  J Gastrointest Oncol       Date:  2020-10

4.  Quantitative body mass characterization before and after head and neck cancer radiotherapy: A challenge of height-weight formulae using computed tomography measurement.

Authors:  Sasikarn Chamchod; Clifton D Fuller; Abdallah S R Mohamed; Aaron Grossberg; Jay A Messer; Jolien Heukelom; G Brandon Gunn; Micheal E Kantor; Hillary Eichelberger; Adam S Garden; David I Rosenthal
Journal:  Oral Oncol       Date:  2016-08-31       Impact factor: 5.337

5.  Weight and Body Composition Compartments do Not Predict Therapeutic Thiopurine Metabolite Levels in Inflammatory Bowel Disease.

Authors:  Darcy Q Holt; Boyd Jg Strauss; Gregory T Moore
Journal:  Clin Transl Gastroenterol       Date:  2016-10-27       Impact factor: 4.488

6.  Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration.

Authors:  Dawesh P Yadav; Saurabh Kedia; Kumble Seetharama Madhusudhan; Sawan Bopanna; Sandeep Goyal; Saransh Jain; Naval K Vikram; Raju Sharma; Govind K Makharia; Vineet Ahuja
Journal:  Can J Gastroenterol Hepatol       Date:  2017-10-31

7.  The prevalence of sarcopenia and its effect on prognosis in patients with Crohn's disease.

Authors:  Chan Hyung Lee; Hyuk Yoon; Dong Jun Oh; Jae Min Lee; Yoon Jin Choi; Cheol Min Shin; Young Soo Park; Nayoung Kim; Dong Ho Lee; Joo Sung Kim
Journal:  Intest Res       Date:  2020-01-30

8.  Correlation Among Body Composition Parameters and Long-Term Outcomes in Crohn's Disease After Anti-TNF Therapy.

Authors:  Katsuyoshi Ando; Kyoko Uehara; Yuya Sugiyama; Yu Kobayashi; Yuki Murakami; Hiroki Sato; Takehito Kunogi; Takahiro Sasaki; Keitaro Takahashi; Nobuhiro Ueno; Shin Kashima; Kentaro Moriichi; Hiroki Tanabe; Toshikatsu Okumura; Mikihiro Fujiya
Journal:  Front Nutr       Date:  2022-04-01

9.  Psoas as a sentinel muscle for sarcopenia: a flawed premise.

Authors:  Vickie E Baracos
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-07-03       Impact factor: 12.910

10.  Thickness of Subcutaneous Fat Is a Predictive Factor of Incisional Surgical Site Infection in Crohn's Disease Surgery: A Retrospective Study.

Authors:  Xingchen Cai; Weisong Shen; Zhen Guo; Yi Li; Lei Cao; Jianfeng Gong; Weiming Zhu
Journal:  Gastroenterol Res Pract       Date:  2018-07-22       Impact factor: 2.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.